Clinical Trial Update: S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial (S0124) comparing cisplatin plus irinotecan versus cisplatin plus etoposide for extensive-stage small cell lung cancer has completed, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)
• Irinotecan (Irinotecan)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2013-07-09